Search Results - "GACCI, MAURO"

Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia by De Nunzio, Cosimo, Salonia, Andrea, Gacci, Mauro, Ficarra, Vincenzo

“…Purpose To review the role of a persistent prostatic inflammatory status (PIS) in the development and progression of benign prostatic hyperplasia (BPH)…”
Get full text

Reappraising the microscopic anatomy of human testis: identification of telocyte networks in the peritubular and intertubular stromal space by Marini, Mirca, Rosa, Irene, Guasti, Daniele, Gacci, Mauro, Sgambati, Eleonora, Ibba-Manneschi, Lidia, Manetti, Mirko

“…Telocytes are a recently described stromal cell type widely distributed in various organs including the female and male reproductive systems. This study was…”
Get full text

Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis by Gacci, Mauro, Corona, Giovanni, Sebastianelli, Arcangelo, Serni, Sergio, De Nunzio, Cosimo, Maggi, Mario, Vignozzi, Linda, Novara, Giacomo, McVary, Kevin T, Kaplan, Steven A, Gravas, Stavros, Chapple, Christopher

“…Abstract Context The correlation among metabolic syndrome, lower urinary tract symptoms (LUTS), and cardiovascular disease (CVD) is well established. In…”
Get full text

Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia by Gacci, Mauro, Eardley, Ian, Giuliano, Francois, Hatzichristou, Dimitris, Kaplan, Steven A, Maggi, Mario, McVary, Kevin T, Mirone, Vincenzo, Porst, Hartmut, Roehrborn, Claus G

“…Abstract Context This review focuses on the relationship among sexual dysfunction (SD), lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia…”
Get full text

Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia by Gacci, Mauro, Andersson, Karl-Erik, Chapple, Christopher, Maggi, Mario, Mirone, Vincenzo, Oelke, Matthias, Porst, Hartmut, Roehrborn, Claus, Stief, Christian, Giuliano, François

“…Abstract Context Several preclinical reports, randomized controlled trials, systematic reviews, and posthoc analyses corroborate the role of phosphodiesterase…”
Get full text

Editorial Comment to Preservation of the internal sphincter and of the proximal urethra during retropubic radical prostatectomy: A safe option for well-selected cases by Mauro, Gacci

Get full text

Impact of Medical Treatments for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia on Ejaculatory Function: A Systematic Review and Meta‐Analysis by Gacci, Mauro, Ficarra, Vincenzo, Sebastianelli, Arcangelo, Corona, Giovanni, Serni, Sergio, Shariat, Shahrokh F., Maggi, Mario, Zattoni, Filiberto, Carini, Marco, Novara, Giacomo

“…Several drugs, currently used to treat lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), can be associated with bothersome sexual…”
Get full text

Isolation and characterization of multipotent progenitor cells from the bowman's capsule of adult human kidneys by SAGRINATI, Costanza, NETTI, Giuseppe Stefano, CARINI, Marco, GESUALDO, Loreto, FRANCINI, Fabio, MAGGI, Enrico, ANNUNZIATO, Francesco, LASAGNI, Laura, SERIO, Mario, ROMAGNANI, Sergio, ROMAGNANI, Paola, MAZZINGHI, Benedetta, LAZZERI, Elena, LIOTTA, Francesco, FROSALI, Francesca, RONCONI, Elisa, MEINI, Claudia, GACCI, Mauro, SQUECCO, Roberta

“…Regenerative medicine represents a critical clinical goal for patients with ESRD, but the identification of renal adult multipotent progenitor cells has…”
Get full text

PDE5 inhibitors blunt inflammation in human BPH: A potential mechanism of action for PDE5 inhibitors in LUTS by Vignozzi, Linda, Gacci, Mauro, Cellai, Ilaria, Morelli, Annamaria, Maneschi, Elena, Comeglio, Paolo, Santi, Raffaella, Filippi, Sandra, Sebastianelli, Arcangelo, Nesi, Gabriella, Serni, Sergio, Carini, Marco, Maggi, Mario

“…BACKGROUND Metabolic syndrome (MetS) and benign prostate hyperplasia (BPH)/low urinary tract symptoms (LUTS) are often comorbid. Chronic inflammation is one of…”
Get full text

Correction to: Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia by De Nunzio, Cosimo, Salonia, Andrea, Gacci, Mauro, Ficarra, Vincenzo

“…The article “Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia”, written by Cosimo De…”
Get full text

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells by Vignozzi, Linda, Cellai, Ilaria, Santi, Raffaella, Lombardelli, Letizia, Morelli, Annamaria, Comeglio, Paolo, Filippi, Sandra, Logiodice, Federica, Carini, Marco, Nesi, Gabriella, Gacci, Mauro, Piccinni, Marie-Pierre, Adorini, Luciano, Maggi, Mario

“…Progression of benign prostatic hyperplasia (BPH) involves chronic inflammation and immune dysregulation. Preclinical studies have demonstrated that prostate…”
Get full text

Human Benign Prostatic Hyperplasia Stromal Cells As Inducers and Targets of Chronic Immuno-Mediated Inflammation by Penna, Giuseppe, Fibbi, Benedetta, Amuchastegui, Susana, Cossetti, Chiara, Aquilano, Francesca, Laverny, Gilles, Gacci, Mauro, Crescioli, Clara, Maggi, Mario, Adorini, Luciano

“…Benign prostatic hyperplasia (BPH), a highly prevalent prostatic condition, could involve an inflammatory component in disease pathogenesis. In this study, we…”
Get full text

Notch Activation Differentially Regulates Renal Progenitors Proliferation and Differentiation Toward the Podocyte Lineage in Glomerular Disorders by Lasagni, Laura, Ballerini, Lara, Angelotti, Maria Lucia, Parente, Eliana, Sagrinati, Costanza, Mazzinghi, Benedetta, Peired, Anna, Ronconi, Elisa, Becherucci, Francesca, Bani, Daniele, Gacci, Mauro, Carini, Marco, Lazzeri, Elena, Romagnani, Paola

“…Glomerular diseases account for 90% of end‐stage kidney disease. Podocyte loss is a common determining factor for the progression toward glomerulosclerosis…”
Get full text

Systematic review and meta‐analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine by Sebastianelli, Arcangelo, Russo, Giorgio I, Kaplan, Steven A, McVary, Kevin T, Moncada, Ignacio, Gravas, Stavros, Chapple, Christopher, Morgia, Giuseppe, Serni, Sergio, Gacci, Mauro

“…A systematic review and meta‐analysis was carried out to evaluate the efficacy and safety of mirabegron 50 mg and 100 mg in the treatment of storage lower…”
Get full text

Contrast-enhanced ultrasound (CEUS) imaging for active surveillance of small renal masses by Bertelli, Elena, Palombella, Alberto, Sessa, Francesco, Baldi, Irene, Morelli, Noemi, Verna, Silvia, Greco, Isabella, Morselli, Simone, Pili, Alessandro, Sebastianelli, Arcangelo, Berni, Alessandro, Nicoletti, Rossella, Minervini, Andrea, Carini, Marco, Gacci, Mauro, Miele, Vittorio, Agostini, Simone, Serni, Sergio, Campi, Riccardo

“…Purpose To assess the safety and efficacy of contrast-enhanced ultrasound (CEUS) imaging for monitoring small (< 4 cm) renal masses (SRM) in patients…”
Get full text

Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base by Gacci, Mauro, Sebastianelli, Arcangelo, Spatafora, Pietro, Corona, Giovanni, Serni, Sergio, De Ridder, Dirk, Gravas, Stavros, Abrams, Paul

“…Storage lower urinary tract symptoms (LUTS) are characterized by an altered bladder sensation, increased daytime frequency, nocturia, urgency and urgency…”
Get full text

Editorial Comment to Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy by Gacci, Mauro

Get full text

Editorial Comment to Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo- and tamsulosin-controlled 12-week study in Asian men by Gacci, Mauro

Get full text

Phosphodiesterase Type 5 Expression in Human and Rat Lower Urinary Tract Tissues and the Effect of Tadalafil on Prostate Gland Oxygenation in Spontaneously Hypertensive Rats by Morelli, Annamaria, Sarchielli, Erica, Comeglio, Paolo, Filippi, Sandra, Mancina, Rosa, Gacci, Mauro, Vignozzi, Linda, Carini, Marco, Vannelli, Gabriella B., Maggi, Mario

“…In humans, prostate phosphodiesterase type 5 inhibitors (PDE5) expression was prominently localized in the endothelial and smooth muscle cells of the vascular…”
Get full text

Characterization and Functional Role of Androgen-Dependent PDE5 Activity in the Bladder by Filippi, Sandra, Morelli, Annamaria, Sandner, Peter, Fibbi, Benedetta, Mancina, Rosa, Marini, Mirca, Gacci, Mauro, Vignozzi, Linda, Vannelli, Gabriella Barbara, Carini, Marco, Forti, Gianni, Maggi, Mario

“…Benign prostate hyperplasia is the most common disease in the aging male, often comorbid with erectile dysfunction. Phosphodiesterase type 5 (PDE5) inhibitors…”
Get full text